Pricing Log in Create free account

Puma Biotechnology, Inc. (PBYI) vs SL SCIENCE HLDG (SLBT)

Puma Biotechnology, Inc. and SL SCIENCE HLDG are both Biotechnology companies. Puma Biotechnology, Inc. and SL SCIENCE HLDG are of similar size ($504.7M and $504.3M). Across the 2 metrics below, Puma Biotechnology, Inc. leads on 1 and SL SCIENCE HLDG on 1.

Valuation

Metric PBYI SLBT Biotechnology median
P/E 15.31 — 10.60
P/S 1.82 — 9.40
P/B 3.04 n/m 2.13
Price to free cash flow 14.74 — 25.18
EV/EBITDA 8.54 n/m 0.66
EV/Sales 1.51 n/m 9.02
Earnings yield 6.53% — (32.88%)
Free cash flow yield 6.78% — (23.13%)

Profitability

Metric PBYI SLBT Biotechnology median
Gross margin 74.83% — 68.51%
Operating margin 13.16% — 0.00%
Net margin 11.55% — 0.00%
Free cash flow margin 17.79% — 0.00%
Return on equity 21.97% — (51.96%)
Return on assets 13.78% — (46.06%)
Return on invested capital 42.61% 0.00% 0.00%

Growth

Metric PBYI SLBT Biotechnology median
Revenue growth (TTM) (2.86%) — 6.76%
EPS growth (last fiscal year) (1.61%) — 29.88%
Revenue growth, 5-year CAGR 0.29% — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric PBYI SLBT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.91 4.44 4.97
Net debt to EBITDA (1.60) — 1.01

Dividend

Metric PBYI SLBT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric PBYI SLBT Biotechnology median
Market cap 504.33m 504.74m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack